02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 10.95
−2.67%Margins
Gross margin
67.8%
EBITDA margin
-140.1%
EBIT margin
-72.4%
Net margin
-65.2%
FCF margin
-136.6%
-8.1%
Return on equity
-5.6%
Return on assets
-8.4%
Return on invested capital
0.10x
Asset turnover
-HKD 205.3M
Cash from operations
HKD 2.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026